Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 171.0B | 153.9B | 157.0B | 172.9B |
Cost of revenue | 104.6B | 93.0B | 92.9B | 111.9B |
Gross profit | 66.4B | 61.0B | 64.1B | 61.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 21.3B | 16.9B | 16.2B | 15.1B |
Operating income | 21.3B | 23.1B | 27.6B | 26.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 12.1B | 11.7B | 11.4B | 11.8B |
Other income expense | — | — | — | — |
Pretax income | 16.0B | 14.6B | 17.7B | 14.9B |
Tax provision | 2.9B | 2.7B | 6.8B | 3.0B |
Net income | 13.1B | 11.9B | 10.9B | 11.9B |
Basic EPS | — | 3.2 | 2.9 | 3.0 |
Diluted EPS | — | 3.2 | 2.9 | 3.0 |
Basic average shares | — | 3.2B | 3.2B | 3.2B |
Diluted average shares | — | 3.2B | 3.2B | 3.2B |
EBITDA | 42.3B | 36.7B | 44.9B | 36.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | -2.6B | -1.6B | -1.7B | -2.2B |
Preferred stock dividends | 0 | 0 | 0 | 0 |